 | • レポートコード：QY2108PAL8820 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるエルウィナーゼの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、エルウィナーゼの種類別市場規模（急性リンパ芽球性白血病、急性骨髄性白血病）、用途別市場規模（子供、大人）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のエルウィナーゼ市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるエルウィナーゼの種類別市場規模（2016年-2027年）：急性リンパ芽球性白血病、急性骨髄性白血病 ・世界におけるエルウィナーゼの用途別市場規模（2016年-2027年）：子供、大人 ・エルウィナーゼの中国市場分析 - エルウィナーゼの中国市場規模（2016年-2027年） - 中国におけるエルウィナーゼの主要プレイヤー別市場シェア - 中国におけるエルウィナーゼの種類別市場規模：急性リンパ芽球性白血病、急性骨髄性白血病 - 中国におけるエルウィナーゼの用途別市場規模：子供、大人 ・エルウィナーゼの北米市場（2016年-2027年） ・エルウィナーゼのヨーロッパ市場（2016年-2027年） ・エルウィナーゼのアジア太平洋市場（2016年-2027年） ・エルウィナーゼの中南米市場（2016年-2027年） ・エルウィナーゼの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Jazz Pharmaceuticals/Porton Biopharma、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect.
Erwinase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. Erwinase® is indicated for the treatment of Acute Lymphoblastic Leukaemia (ALL), a type of cancer that particularly affects children. Erwinase® is an asparaginase enzyme derived from the bacterium Erwinia chrysanthemi that is used as part of the treatment protocols in conjunction with radiotherapy or chemotherapy. In the last several years, In the past few years, the market has been in a state of insufficient supply. The main reason is that the manufacturer’s production status is not stable, and at the same time, some batches of drugs have been damaged due to the contamination of the site.Erwinase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Erwinase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 95% in 2019.
Market Analysis and Insights: Global and China Erwinase Market
This report focuses on global and China Erwinase market.
In 2020, the global Erwinase market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Erwinase market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Erwinase Scope and Market Size
Erwinase market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Erwinase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Erwinase market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Segment by Application
Child
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Jazz Pharmaceuticals/Porton Biopharma
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
1 Study Coverage
1.1 Erwinase Product Introduction
1.2 Market by Type
1.2.1 Global Erwinase Market Size Growth Rate by Type
1.2.2 Acute Lymphoblastic Leukemia
1.2.3 Acute Myeloid Leukemia
1.3 Market by Application
1.3.1 Global Erwinase Market Size Growth Rate by Application
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erwinase Market Size, Estimates and Forecasts
2.1.1 Global Erwinase Revenue 2016-2027
2.1.2 Global Erwinase Sales 2016-2027
2.2 Global Erwinase, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Erwinase Historical Market Size by Region (2016-2021)
2.3.1 Global Erwinase Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Erwinase Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Erwinase Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Erwinase Sales Forecast by Region (2022-2027)
2.4.2 Global Erwinase Revenue Forecast by Region (2022-2027)
3 Global Erwinase Competitor Landscape by Players
3.1 Global Top Erwinase Manufacturers by Sales
3.1.1 Global Erwinase Sales by Manufacturer (2016-2021)
3.1.2 Global Erwinase Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Erwinase Manufacturers by Revenue
3.2.1 Key Erwinase Manufacturers Covered: Ranking by Revenue
3.2.2 Global Erwinase Revenue by Manufacturers (2016-2021)
3.2.3 Global Erwinase Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Erwinase Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Erwinase Revenue in 2020
3.2.6 Global Erwinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Erwinase Price by Manufacturers
3.4 Global Erwinase Manufacturing Base Distribution, Product Types
3.4.1 Erwinase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erwinase Product Type
3.4.3 Date of International Manufacturers Enter into Erwinase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Erwinase Market Size by Type (2016-2021)
4.1.1 Global Erwinase Sales by Type (2016-2021)
4.1.2 Global Erwinase Revenue by Type (2016-2021)
4.1.3 Erwinase Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Erwinase Market Size Forecast by Type (2022-2027)
4.2.1 Global Erwinase Sales Forecast by Type (2022-2027)
4.2.2 Global Erwinase Revenue Forecast by Type (2022-2027)
4.2.3 Erwinase Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Erwinase Market Size by Application (2016-2021)
5.1.1 Global Erwinase Sales by Application (2016-2021)
5.1.2 Global Erwinase Revenue by Application (2016-2021)
5.1.3 Erwinase Price by Application (2016-2021)
5.2 Erwinase Market Size Forecast by Application (2022-2027)
5.2.1 Global Erwinase Sales Forecast by Application (2022-2027)
5.2.2 Global Erwinase Revenue Forecast by Application (2022-2027)
5.2.3 Global Erwinase Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Erwinase Market Size YoY Growth 2016-2027
6.1.1 China Erwinase Sales YoY Growth 2016-2027
6.1.2 China Erwinase Revenue YoY Growth 2016-2027
6.1.3 China Erwinase Market Share in Global Market 2016-2027
6.2 China Erwinase Market Size by Players (International and Local Players)
6.2.1 China Top Erwinase Players by Sales (2016-2021)
6.2.2 China Top Erwinase Players by Revenue (2016-2021)
6.3 China Erwinase Historic Market Review by Type (2016-2021)
6.3.1 China Erwinase Sales Market Share by Type (2016-2021)
6.3.2 China Erwinase Revenue Market Share by Type (2016-2021)
6.3.3 China Erwinase Price by Type (2016-2021)
6.4 China Erwinase Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Erwinase Sales Forecast by Type (2022-2027)
6.4.2 China Erwinase Revenue Forecast by Type (2022-2027)
6.4.3 China Erwinase Price Forecast by Type (2022-2027)
6.5 China Erwinase Historic Market Review by Application (2016-2021)
6.5.1 China Erwinase Sales Market Share by Application (2016-2021)
6.5.2 China Erwinase Revenue Market Share by Application (2016-2021)
6.5.3 China Erwinase Price by Application (2016-2021)
6.6 China Erwinase Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Erwinase Sales Forecast by Application (2022-2027)
6.6.2 China Erwinase Revenue Forecast by Application (2022-2027)
6.6.3 China Erwinase Price Forecast by Application (2022-2027)
7 North America
7.1 North America Erwinase Market Size YoY Growth 2016-2027
7.2 North America Erwinase Market Facts & Figures by Country
7.2.1 North America Erwinase Sales by Country (2016-2021)
7.2.2 North America Erwinase Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Erwinase Market Size YoY Growth 2016-2027
8.2 Asia Pacific Erwinase Market Facts & Figures by Region
8.2.1 Asia Pacific Erwinase Sales by Region (2016-2021)
8.2.2 Asia Pacific Erwinase Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Erwinase Market Size YoY Growth 2016-2027
9.2 Europe Erwinase Market Facts & Figures by Country
9.2.1 Europe Erwinase Sales by Country (2016-2021)
9.2.2 Europe Erwinase Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Erwinase Market Size YoY Growth 2016-2027
10.2 Latin America Erwinase Market Facts & Figures by Country
10.2.1 Latin America Erwinase Sales by Country (2016-2021)
10.2.2 Latin America Erwinase Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Erwinase Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Erwinase Market Facts & Figures by Country
11.2.1 Middle East and Africa Erwinase Sales by Country (2016-2021)
11.2.2 Middle East and Africa Erwinase Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Jazz Pharmaceuticals/Porton Biopharma
12.1.1 Jazz Pharmaceuticals/Porton Biopharma Corporation Information
12.1.2 Jazz Pharmaceuticals/Porton Biopharma Description and Business Overview
12.1.3 Jazz Pharmaceuticals/Porton Biopharma Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jazz Pharmaceuticals/Porton Biopharma Erwinase Products Offered
12.1.5 Jazz Pharmaceuticals/Porton Biopharma Recent Development
12.2 Shire
12.2.1 Shire Corporation Information
12.2.2 Shire Description and Business Overview
12.2.3 Shire Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shire Erwinase Products Offered
12.2.5 Shire Recent Development
12.3 Medac GmbH
12.3.1 Medac GmbH Corporation Information
12.3.2 Medac GmbH Description and Business Overview
12.3.3 Medac GmbH Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Medac GmbH Erwinase Products Offered
12.3.5 Medac GmbH Recent Development
12.4 Kyowa Hakko Kirin
12.4.1 Kyowa Hakko Kirin Corporation Information
12.4.2 Kyowa Hakko Kirin Description and Business Overview
12.4.3 Kyowa Hakko Kirin Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kyowa Hakko Kirin Erwinase Products Offered
12.4.5 Kyowa Hakko Kirin Recent Development
12.5 Qianhong Bio-pharma
12.5.1 Qianhong Bio-pharma Corporation Information
12.5.2 Qianhong Bio-pharma Description and Business Overview
12.5.3 Qianhong Bio-pharma Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Qianhong Bio-pharma Erwinase Products Offered
12.5.5 Qianhong Bio-pharma Recent Development
12.6 Taj Pharmaceuticals
12.6.1 Taj Pharmaceuticals Corporation Information
12.6.2 Taj Pharmaceuticals Description and Business Overview
12.6.3 Taj Pharmaceuticals Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Taj Pharmaceuticals Erwinase Products Offered
12.6.5 Taj Pharmaceuticals Recent Development
12.7 Mingxing Pharma
12.7.1 Mingxing Pharma Corporation Information
12.7.2 Mingxing Pharma Description and Business Overview
12.7.3 Mingxing Pharma Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mingxing Pharma Erwinase Products Offered
12.7.5 Mingxing Pharma Recent Development
12.8 SL Pharma
12.8.1 SL Pharma Corporation Information
12.8.2 SL Pharma Description and Business Overview
12.8.3 SL Pharma Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.8.4 SL Pharma Erwinase Products Offered
12.8.5 SL Pharma Recent Development
12.9 United Biotech
12.9.1 United Biotech Corporation Information
12.9.2 United Biotech Description and Business Overview
12.9.3 United Biotech Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.9.4 United Biotech Erwinase Products Offered
12.9.5 United Biotech Recent Development
12.11 Jazz Pharmaceuticals/Porton Biopharma
12.11.1 Jazz Pharmaceuticals/Porton Biopharma Corporation Information
12.11.2 Jazz Pharmaceuticals/Porton Biopharma Description and Business Overview
12.11.3 Jazz Pharmaceuticals/Porton Biopharma Erwinase Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Jazz Pharmaceuticals/Porton Biopharma Erwinase Products Offered
12.11.5 Jazz Pharmaceuticals/Porton Biopharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Erwinase Industry Trends
13.2 Erwinase Market Drivers
13.3 Erwinase Market Challenges
13.4 Erwinase Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erwinase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Erwinase Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Acute Lymphoblastic Leukemia
Table 3. Major Manufacturers of Acute Myeloid Leukemia
Table 4. Global Erwinase Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Erwinase Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Erwinase Sales by Regions (2016-2021) & (K Units)
Table 7. Global Erwinase Sales Market Share by Regions (2016-2021)
Table 8. Global Erwinase Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Erwinase Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Erwinase Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Erwinase Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Erwinase Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Erwinase Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Erwinase Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Erwinase Manufacturers by Revenue (US$ Million) in 2020
Table 16. Erwinase Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Erwinase Revenue Share by Manufacturers (2016-2021)
Table 18. Global Erwinase Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Erwinase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erwinase as of 2020)
Table 20. Key Manufacturers Erwinase Price (2016-2021) (US$/Unit)
Table 21. Erwinase Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Erwinase Product Type
Table 23. Date of International Manufacturers Enter into Erwinase Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Erwinase Sales by Type (2016-2021) (K Units)
Table 26. Global Erwinase Sales Share by Type (2016-2021)
Table 27. Global Erwinase Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Erwinase Revenue Share by Type (2016-2021)
Table 29. Erwinase Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Erwinase Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Erwinase Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Erwinase Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Erwinase Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Erwinase Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Erwinase Sales by Application (2016-2021) (K Units)
Table 36. Global Erwinase Sales Share by Application (2016-2021)
Table 37. Global Erwinase Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Erwinase Revenue Share by Application (2016-2021)
Table 39. Erwinase Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Erwinase Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Erwinase Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Erwinase Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Erwinase Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Erwinase Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Erwinase Sales (K Units) of Key Companies (2016-2021)
Table 46. China Erwinase Sales Share by Company (2016-2021)
Table 47. China Erwinase Revenue (US$ Million) by Company (2016-2021)
Table 48. China Erwinase Revenue Share by Company (2016-2021)
Table 49. China Erwinase Sales (K Units) by Type (2016-2021)
Table 50. China Erwinase Sales Share by Type (2016-2021)
Table 51. China Erwinase Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Erwinase Price (US$/Unit) by Type (2016-2021)
Table 53. China Erwinase Sales (K Units) by Type (2022-2027)
Table 54. China Erwinase Sales Share by Type (2022-2027)
Table 55. China Erwinase Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Erwinase Revenue Share by Type (2022-2027)
Table 57. China Erwinase Price (US$/Unit) by Type (2022-2027)
Table 58. China Erwinase Sales (K Units) by Application (2016-2021)
Table 59. China Erwinase Sales Share by Application (2016-2021)
Table 60. China Erwinase Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Erwinase Price (US$/Unit) by Application (2016-2021)
Table 62. China Erwinase Sales (K Units) by Application (2022-2027)
Table 63. China Erwinase Sales Share by Application (2022-2027)
Table 64. China Erwinase Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Erwinase Revenue Share by Application (2022-2027)
Table 66. China Erwinase Price (US$/Unit) by Application (2022-2027)
Table 67. North America Erwinase Sales by Country (2016-2021) & (K Units)
Table 68. North America Erwinase Sales Market Share by Country (2016-2021)
Table 69. North America Erwinase Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Erwinase Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Erwinase Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Erwinase Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Erwinase Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Erwinase Revenue Market Share by Region (2016-2021)
Table 75. Europe Erwinase Sales by Country (2016-2021) & (K Units)
Table 76. Europe Erwinase Sales Market Share by Country (2016-2021)
Table 77. Europe Erwinase Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Erwinase Revenue Market Share by Country (2016-2021)
Table 79. Latin America Erwinase Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Erwinase Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Erwinase Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Erwinase Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Erwinase Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Erwinase Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Erwinase Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Erwinase Revenue Market Share by Country (2016-2021)
Table 87. Jazz Pharmaceuticals/Porton Biopharma Corporation Information
Table 88. Jazz Pharmaceuticals/Porton Biopharma Description and Business Overview
Table 89. Jazz Pharmaceuticals/Porton Biopharma Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. Jazz Pharmaceuticals/Porton Biopharma Erwinase Product
Table 91. Jazz Pharmaceuticals/Porton Biopharma Recent Development
Table 92. Shire Corporation Information
Table 93. Shire Description and Business Overview
Table 94. Shire Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Shire Product
Table 96. Shire Recent Development
Table 97. Medac GmbH Corporation Information
Table 98. Medac GmbH Description and Business Overview
Table 99. Medac GmbH Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Medac GmbH Product
Table 101. Medac GmbH Recent Development
Table 102. Kyowa Hakko Kirin Corporation Information
Table 103. Kyowa Hakko Kirin Description and Business Overview
Table 104. Kyowa Hakko Kirin Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Kyowa Hakko Kirin Product
Table 106. Kyowa Hakko Kirin Recent Development
Table 107. Qianhong Bio-pharma Corporation Information
Table 108. Qianhong Bio-pharma Description and Business Overview
Table 109. Qianhong Bio-pharma Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Qianhong Bio-pharma Product
Table 111. Qianhong Bio-pharma Recent Development
Table 112. Taj Pharmaceuticals Corporation Information
Table 113. Taj Pharmaceuticals Description and Business Overview
Table 114. Taj Pharmaceuticals Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Taj Pharmaceuticals Product
Table 116. Taj Pharmaceuticals Recent Development
Table 117. Mingxing Pharma Corporation Information
Table 118. Mingxing Pharma Description and Business Overview
Table 119. Mingxing Pharma Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Mingxing Pharma Product
Table 121. Mingxing Pharma Recent Development
Table 122. SL Pharma Corporation Information
Table 123. SL Pharma Description and Business Overview
Table 124. SL Pharma Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. SL Pharma Product
Table 126. SL Pharma Recent Development
Table 127. United Biotech Corporation Information
Table 128. United Biotech Description and Business Overview
Table 129. United Biotech Erwinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. United Biotech Product
Table 131. United Biotech Recent Development
Table 132. Erwinase Market Trends
Table 133. Erwinase Market Drivers
Table 134. Erwinase Market Challenges
Table 135. Erwinase Market Restraints
Table 136. Erwinase Customers List
Table 137. Erwinase Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Erwinase Product Picture
Figure 2. Global Erwinase Sales Market Share by Type in 2020 & 2027
Figure 3. Acute Lymphoblastic Leukemia Product Picture
Figure 4. Acute Myeloid Leukemia Product Picture
Figure 5. Global Erwinase Sales Market Share by Application in 2020 & 2027
Figure 6. Child
Figure 7. Adult
Figure 8. Erwinase Report Years Considered
Figure 9. Global Erwinase Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Erwinase Market Size 2016-2027 (US$ Million)
Figure 11. Global Erwinase Sales 2016-2027 (K Units)
Figure 12. Global Erwinase Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Erwinase Sales Market Share by Region (2016-2021)
Figure 14. Global Erwinase Sales Market Share by Region in 2020
Figure 15. Global Erwinase Revenue Market Share by Region (2016-2021)
Figure 16. Global Erwinase Revenue Market Share by Region in 2020
Figure 17. Global Erwinase Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Erwinase Revenue in 2020
Figure 19. Erwinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Erwinase Sales Market Share by Type (2016-2021)
Figure 21. Global Erwinase Sales Market Share by Type in 2020
Figure 22. Global Erwinase Revenue Market Share by Type (2016-2021)
Figure 23. Global Erwinase Revenue Market Share by Type in 2020
Figure 24. Global Erwinase Sales Market Share by Application (2016-2021)
Figure 25. Global Erwinase Sales Market Share by Application in 2020
Figure 26. Global Erwinase Revenue Market Share by Application (2016-2021)
Figure 27. Global Erwinase Revenue Market Share by Application in 2020
Figure 28. China Erwinase Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Erwinase Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Erwinase Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Erwinase Players Market Share by Revenue in Erwinase in 2020
Figure 32. China Erwinase Revenue Share by Type (2016-2021)
Figure 33. China Erwinase Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Erwinase Revenue Share by Application (2016-2021)
Figure 35. China Erwinase Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Erwinase Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Erwinase Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Erwinase Sales Market Share by Country in 2020
Figure 39. North America Erwinase Revenue Market Share by Country in 2020
Figure 40. U.S. Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Erwinase Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Erwinase Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Erwinase Sales Market Share by Country in 2020
Figure 47. Europe Erwinase Revenue Market Share by Country in 2020
Figure 48. Germany Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Erwinase Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Erwinase Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Erwinase Sales Market Share by Region in 2020
Figure 61. Asia Pacific Erwinase Revenue Market Share by Region in 2020
Figure 62. China Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Erwinase Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Erwinase Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Erwinase Sales Market Share by Country in 2020
Figure 87. Latin America Erwinase Revenue Market Share by Country in 2020
Figure 88. Mexico Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Erwinase Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Erwinase Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Erwinase Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Erwinase Revenue Market Share by Country in 2020
Figure 98. Turkey Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Erwinase Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Erwinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Erwinase Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
エルウィナーゼの世界市場 2020年 Market Overview The Erwinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 再発急性骨髄性白血病（AML）治療薬の世界市場 2020年 Market Overview The global Relapsed Acute Myeloid Leukemia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Relapsed…
- サークル急性虚血性脳卒中の世界及び中国市場 Acute ischemic stroke occurs when blood flow through a brain artery is blocked by a clot, a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, the most common of the two, occurs when a clot forms within an artery in …
- 急性期人工呼吸器の世界及び中国市場 When it comes to critical care transportation, one of the key pieces of equipment to have on-hand is a portable ventilator. In addition to oxygenation, perfusion, and circulation, ventilation is one of the vital functions that must be sustained while transporting a patient to a critical care facilit…
- 血液がん治療の世界市場 2020年 Market Overview The global Blood Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Cancer Therap…